Mycobacterial strains are potent inducers of cytokines/chemokines by mononuclear phagocytes, which constitute an important cellular component of the first line of defense in the innate immune system. Interferon (IFN)-γ-inducible protein (IP-10 or CXCL10) is a potent chemoattractant; however, little is known about the IP-10 profiles attributable to the Th1 regulation associated with active tuberculosis (TB). In this study, we investigated the production of IP-10, interleukin (IL)-12 p40, and IFN-γ by the peripheral blood mononuclear cells (PBMCs) of patients with active pulmonary TB in response to in vitro stimulation with Triton X-100 soluble proteins (TSPs) or the 30-kDa antigen. The TSP antigens used in the present study were isolated and purified from Mycobacterium tuberculosis H37Rv (virulent strain), M. tuberculosis H37Ra (avirulent strain), and Mycobacterium bovis BCG. The results were compared with those obtained for healthy tuberculin reactors (HTRs). Concordant with earlier studies, IFN-γ production was significantly depressed in the PBMCs from TB patients compared with those in the HTR group. However, the IP-10 levels in the PBMCs from TB patients were significantly elevated 18 h after stimulation compared to those in the PBMCs from HTRs. IP-10 release was correlated in a significant manner with the release of IFN-γ in the HTRs, but this was not the case for the TB patients. Collectively, these data suggest that TB patients show altered regulation of Th1-driving cytokine and chemokine production in response to a variety of mycobacterial antigens.
INTRODUCTION
Tuberculosis (TB) remains the leading cause of morbidity and mortality due to an infectious agent worldwide, although the understanding of its immunopathogenesis remains incomplete (35). The immune response mounted to TB infection is generally successful in containing, but not eliminating, the pathogen. Acute active TB can result in a small percentage of infections, probably due to the lack of initiation of appropriate immune responses. During TB infection, Mycobacterium tuberculosis persists in macrophages within granulomas in the organs of infected hosts (9) . With respect to host immune responses, macrophagemycobacterium interactions play crucial roles in bacterial growth inhibition/killing, the recruitment of accessory immune cells for a local inflammatory response, and the presentation of antigens to T cells for the development of acquired immunity. In addition, interactions between macrophages and other effector cells occur in a milieu of both cytokines and chemokines (29) .
Chemokines serve to attract and activate other inflammatory effector cells, including lymphocytes (29) . A variety of experiments have shown that excessive or insufficient production of cytokines and chemokines may significantly contribute to the pathophysiology of TB. During TB, the mononuclear phagocyte migratory activity is a highly regulated process that requires a defined repertoire of chemokines/receptors, and dysregulated expression of these proteins may alter inflammatory effector cells' recruitment and activation (4) . A more complete understanding of the roles that cytokines and chemokines play in the protection against or exacerbation of TB would enhance the development of preventive and therapeutic strategies against M.
tuberculosis.
The active TB is characterized by a profound and prolonged suppression of M. tuberculosis-specific T-cell responses, as shown by the decreased production of the cytokines interferon (IFN)-γ and interleukin (IL)-2 (12, 31, 32) . IFN-γ rapidly induces the expression of genes in macrophages and other cell types (25) , and one of these genes encodes the 10-kDa secreted protein CXCL10, which shares significant homology with a family of chemotactic and mitogenic proteins (24) . CXCL10, which is also called IFN-γ-inducible protein 10 (IP-10), is a member of the CXCchemokine family. It is expressed in lymphocytes and monocytes (15) , and is involved in trafficking monocytes and activated Th1 cells to inflamed foci through interaction with the CXCR3 chemokine receptor. High levels of IP-10 have been found in the delayed-type hypersensitivity reaction to tuberculin purified protein derivative (PPD) (15) , in lymph nodes and lung tuberculous granulomas (8) , in the pleural effusions of TB patients (27) , in the plasma of TB patients (2, 14) , and in patients co-infected with TB and HIV who are experiencing immune reconstitution syndrome (5). 
MATERIALS AND METHODS

Subjects
Whole blood was obtained by venipuncture from a total of ten patients and ten HTRs. All subjects gave their written informed consent before being enrolled in the study. The HTR subjects were recruited from medical college students at Chungnam National University, Korea, and they had no essential amino acids, 100 IU/ml penicillin G, and 100 µg/ ml streptomycin]. PBMCs were then stimulated with 1.0 µg/ml 30-kDa Ag and incubated at 37℃ in a humidified, 5% CO 2 atmosphere until used for supernatant collection.
Lipopolysaccharide (LPS) (1 µg/ml; Sigma Chemical Co.) and phytohemagglutinin (PHA) (1 µg/ml; Sigma Chemical Co.) were used as positive controls for the Ag stimulation in this study.
Enzyme-linked immunosorbent assay
A sandwich enzyme-linked immunosorbent assay (ELISA) was used to detect human IFN-γ, IL-12 p40, and IP-10 (BD PharMingen, San Diego, CA, USA) in culture supernatants. Assays were performed as recommended by the manufacturers. The cytokine concentrations in the samples were calculated using standard curves generated for recombinant cytokines, and the results are expressed in pg/ ml. The difference between duplicate wells was consistently less than 10% of the mean.
Statistical analysis
For statistical analysis, the data obtained from independent experiments were presented as the mean ± SD and analyzed using the Student's t-test or linear regression analysis. Differences were considered to be significant at p<0.05. (Fig. 2A) .
Meanwhile, the production levels of IL-12 p40 following stimulation with TSP-Rv, TSP-Ra, TSP-BCG, and 30-kDa Ag did not show significant differences between the HTRs and TB patients (Fig. 2B) . These data clearly show that the production of IFN-γ, but not of IL-12 p40, by the PBMCs of TB patients is down-regulated by a variety of mycobacterial Ags. were no significant differences in IP-10 production between the TB patients and HTRs after 96 h stimulation (Fig. 3A and B). We found no differences in the patterns of IP-10 production for the different TSP Ags or 30-kDa Ag used to stimulate the PBMCs. Interestingly, the production of IP-10 by each individual correlated significantly with the production of IFN-γ in response to the TSP-Rv and 30-kDa Ag in the HTRs (n=10, r=0.84, and p<0.05 for 30-kDa Ag; n=9, r=0.74, and p<0.05 for TSP-Rv), although this tendency was not found in TB patients (Fig. 4) . The lack of a strong correlation between IFN-γ and IP-10 production in TB patients indicates the altered regulation of Th1-driving cyto- The present data also demonstrate the lack of correlation between IFN-γ and IP-10 production in TB patients, although the significant correlation in HTRs implies that Th1-type cytokine and chemokine production against a variety of mycobacterial Ags is not optimally regulated in TB patients.
IP-10 production by
Previous studies have shown altered regulation of cytokine production in pulmonary TB, which suggests that dysregulated cytokine production contributes to the immunopathogenesis of human TB (19, 20, 21) . 
